ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Stanley Reimann: How One Man Saved a Research Institute

October 28, 2021

Report Urges Better Working Conditions For Postdocs.

October 6, 2000

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008

Bill Planned To Okay Medicare/Medicaid Payment For 100% Of Outpatient Anticancer Drug Costs

February 16, 1979

Obey Explains Cuts In Control, Construction Funds; House Passes HEW Appropriations Bill

July 6, 1979

NCI Advisory Group, Other Cancer Meetings

May 29, 1987